Zhejiang Taimei Medical Technology Co., Ltd. ^2576.HK

Finances

	2024	2023	2022	2021
Revenue	551.156 M ^{-3.84 %}	573.137 M ^{4.36 %}	549.215 M ^{17.81 %}	466.181 M
Net income	-214.609 M ^{38.11 %}	-346.778 M ^{16.02 %}	-412.907 M ^{13.91 %}	-479.611 M
Income before tax	-217.405 M ^{38.99 %}	-356.364 M ^{15.67 %}	-422.581 M ^{11.89 %}	-479.605 M
Income before tax ratio	-0.39 ^{36.56 %}	-0.62 ^{19.19 %}	-0.77 ^{25.21 %}	-1.03
EBITDA	-176.732 M ^{41.67 %}	-302.971 M ^{16.85 %}	-364.375 M ^{17.26 %}	-440.390 M
Net income ratio	-0.39 ^{35.65 %}	-0.61 ^{19.52 %}	-0.75 ^{26.92 %}	-1.03
Ratio EBITDA	-0.32 ^{39.34 %}	-0.53 ^{20.32 %}	-0.66 ^{29.77 %}	-0.94
Gross profit ratio	0.41 ^{30.68 %}	0.31 ^{-7.48 %}	0.34 ^{-3.80 %}	0.35
Weighted average shs out dil	563.779 M ^{0.60 %}	560.417 M ^{0.00 %}	560.417 M ^{0.00 %}	560.417 M
Weighted average shs out	563.779 M ^{0.60 %}	560.417 M ^{0.00 %}	560.417 M ^{0.00 %}	560.417 M
EPS diluted	-0.39 ^{37.10 %}	-0.62 ^{16.22 %}	-0.74 ^{13.95 %}	-0.86
Earnings per share	-0.39 ^{37.10 %}	-0.62 ^{16.22 %}	-0.74 ^{13.95 %}	-0.86
Gross profit	224.943 M ^{25.67 %}	179.002 M ^{-3.45 %}	185.401 M ^{13.34 %}	163.586 M
Income tax expense	0.000 ^{-100.00 %}	15.000 K	0.000 ^{-100.00 %}	6.000 K
Cost of revenue	326.213 M ^{-17.23 %}	394.135 M ^{8.33 %}	363.814 M ^{20.53 %}	301.848 M
General and administrative expenses	297.158 M ^{24.83 %}	238.056 M ^{445.05 %}	43.676 M ^{4.58 %}	41.762 M
Selling and marketing expenses	84.862 M ^{-42.20 %}	146.830 M ^{2 664.12 %}	5.312 M ^{19.18 %}	4.457 M
Other expenses	8.321 M ^{-61.32 %}	21.512 M ^{-93.77 %}	345.512 M ^{-13.33 %}	398.658 M
Operating expenses	477.395 M ^{-17.06 %}	575.589 M ^{-8.37 %}	628.185 M ^{-6.24 %}	669.967 M
Cost and expenses	803.608 M ^{-17.13 %}	969.724 M ^{-2.25 %}	991.999 M ^{2.08 %}	971.815 M
Research and development expenses	87.054 M ^{-48.55 %}	169.191 M ^{-27.60 %}	233.685 M ^{3.82 %}	225.090 M
Selling general and administrative expenses	382.020 M ^{-0.74 %}	384.886 M ^{685.67 %}	48.988 M ^{5.99 %}	46.219 M
Interest income	35.774 M ^{-14.12 %}	41.654 M ^{82.02 %}	22.884 M ^{-20.37 %}	28.738 M
Interest expense	727.000 K ^{-49.20 %}	1.431 M ^{-46.62 %}	2.681 M ^{-1.03 %}	2.709 M
Depreciation and amortization	39.946 M ^{-23.12 %}	51.962 M ^{-6.42 %}	55.525 M ^{52.10 %}	36.506 M
Operating income	-252.452 M ^{36.34 %}	-396.587 M ^{10.43 %}	-442.784 M ^{12.43 %}	-505.634 M
Operating income ratio	-0.46 ^{33.81 %}	-0.69 ^{14.17 %}	-0.81 ^{25.67 %}	-1.08
Total other income expenses net	35.047 M ^{-12.87 %}	40.223 M ^{99.09 %}	20.203 M ^{-22.38 %}	26.029 M
	2024	2023	2022	2021

	2024	2023	2022	2021
Net debt	-284.539 M ^{43.41 %}	-502.835 M ^{19.01 %}	-620.882 M ^{-3.16 %}	-601.869 M
Total investments	880.086 M ^{60.00 %}	550.059 M ^{-25.78 %}	741.080 M ^{2.88 %}	720.300 M
Total debt	34.758 M ^{130.35 %}	15.089 M ^{-67.10 %}	45.860 M ^{-40.78 %}	77.444 M
Accumulated other comprehensive income loss	0.000	0.000	0.000	0.000
Retained earnings	-1.703 B ^{-14.42 %}	-1.488 B ^{-30.37 %}	-1.142 B ^{-56.66 %}	-728.783 M
Common stock	563.779 M ^{4.79 %}	538.000 M ^{0.00 %}	538.000 M ^{0.00 %}	538.000 M
Total equity	1.235 B ^{18.47 %}	1.042 B ^{-24.67 %}	1.383 B ^{-1.96 %}	1.411 B
Other non current liabilities	35.347 M ^{4.78 %}	33.735 M ^{4.66 %}	32.232 M	0.000
Long term debt	13.283 M ^{377.63 %}	2.781 M ^{-80.34 %}	14.146 M ^{-65.37 %}	40.847 M
Total non current liabilities	56.032 M ^{25.38 %}	44.690 M ^{-11.57 %}	50.535 M ^{14.53 %}	44.125 M
Other current liabilities	159.203 M ^{-34.20 %}	241.960 M ^{-3.59 %}	250.973 M ^{-1.48 %}	254.740 M
Deferred revenue	0.000	0.000	0.000	0.000
Short term debt	21.475 M ^{-16.95 %}	25.859 M ^{-61.59 %}	67.321 M ^{83.95 %}	36.597 M
Total current liabilities	292.592 M ^{-18.24 %}	357.869 M ^{-8.57 %}	391.432 M ^{11.96 %}	349.622 M
Total liabilities	348.624 M ^{-13.40 %}	402.559 M ^{-8.92 %}	441.967 M ^{12.25 %}	393.747 M
Other non current assets	10.451 M ^{234.05 %}	-7.797 M	0.000	0.000
Long term investments	0.000 ^{-100.00 %}	5.505 M	0.000	0.000
Intangible assets	21.173 M ^{-24.25 %}	27.952 M ^{9.49 %}	25.530 M ^{-0.37 %}	25.624 M
GoodWill	37.008 M ^{-28.18 %}	51.530 M ^{-6.60 %}	55.171 M ^{-28.86 %}	77.553 M
Goodwill and intangible assets	58.181 M ^{-26.80 %}	79.483 M ^{-1.51 %}	80.701 M ^{-21.78 %}	103.177 M
Property plant equipment net	37.465 M ^{-9.26 %}	41.289 M ^{-51.36 %}	84.894 M ^{-22.83 %}	110.003 M
Total non current assets	106.097 M ^{-10.45 %}	118.480 M ^{-28.45 %}	165.595 M ^{-22.32 %}	213.180 M
Other current assets	90.213 M ^{12.72 %}	80.033 M ^{-9.63 %}	88.565 M ^{26.29 %}	70.130 M
Short term investments	880.086 M ^{60.00 %}	550.059 M ^{-25.78 %}	741.080 M ^{2.88 %}	720.300 M
cash and cash equivalents	319.297 M ^{-38.35 %}	517.924 M ^{-22.32 %}	666.742 M ^{-1.85 %}	679.313 M
Cash and short term investments	1.199 B ^{12.30 %}	1.068 B ^{-24.14 %}	1.408 B ^{0.59 %}	1.400 B
Total current assets	1.477 B ^{11.38 %}	1.326 B ^{-20.09 %}	1.660 B ^{4.28 %}	1.592 B
Inventory	0.000	0.000	0.000	0.000
Net receivables	187.504 M ^{5.24 %}	178.176 M ^{9.10 %}	163.319 M ^{34.04 %}	121.847 M
Tax assets	0.000	0.000	0.000	0.000
Other assets	0.000	0.000	0.000	0.000
Account payables	99.961 M ^{41.35 %}	70.720 M ^{46.96 %}	48.122 M ^{12.57 %}	42.750 M
Tax payables	11.953 M ^{-38.16 %}	19.330 M ^{-22.73 %}	25.016 M ^{61.03 %}	15.535 M
Deferred revenue non current	7.402 M ^{-9.44 %}	8.174 M ^{96.63 %}	4.157 M ^{26.82 %}	3.278 M
Minority interest	76.763 M ^{20.34 %}	63.786 M ^{-13.09 %}	73.397 M	0.000
Capital lease obligations	24.754 M ^{64.05 %}	15.089 M ^{-67.10 %}	45.860 M ^{-40.78 %}	77.444 M
Preferred stock	0.000	0.000	0.000	0.000
Other total stockholders equity	2.297 B ^{19.10 %}	1.929 B ^{0.79 %}	1.914 B ^{19.47 %}	1.602 B
Deferred tax liabilities non current	0.000	0.000	0.000	0.000
Other liabilities	0.000	0.000	0.000	0.000
Total assets	1.583 B ^{9.59 %}	1.445 B ^{-20.85 %}	1.825 B ^{1.14 %}	1.805 B
	2024	2023	2022	2021

	2024	2023	2022	2021
Deferred income tax	0.000	0.000	0.000	0.000
Stock based compensation	129.419 M ^{873.66 %}	13.292 M ^{-85.11 %}	89.275 M ^{-33.59 %}	134.427 M
Change in working capital	-117.499 M ^{-460.32 %}	-20.970 M ^{-554.29 %}	-3.205 M ^{-104.51 %}	71.059 M
Accounts receivables	-38.772 M ^{-336.33 %}	-8.886 M ^{83.29 %}	-53.176 M ^{34.16 %}	-80.765 M
Inventory	0.000	0.000	0.000	0.000
Accounts payables	0.000	0.000	0.000	0.000
Other working capital	-78.727 M ^{-551.50 %}	-12.084 M ^{-124.18 %}	49.971 M ^{-67.09 %}	151.824 M
Other non cash items	-36.076 M ^{-194.28 %}	-12.259 M ^{74.58 %}	-48.234 M ^{-340.20 %}	20.081 M
Net cash provided by operating activities	-201.615 M ^{42.59 %}	-351.164 M ^{-6.67 %}	-329.220 M ^{-51.34 %}	-217.532 M
Investments in property plant and equipment	-6.161 M ^{-41.33 %}	-4.359 M ^{82.13 %}	-24.399 M ^{18.93 %}	-30.095 M
Acquisitions net	0.000	0.000	0.000	0.000
Purchases of investments	-1.236 B ^{-74.59 %}	-707.915 M ^{69.02 %}	-2.285 B ^{7.76 %}	-2.477 B
Sales maturities of investments	924.444 M ^{-1.10 %}	934.763 M ^{-59.08 %}	2.284 B ^{11.44 %}	2.050 B
Other investing activites	33.983 M ^{123.58 %}	15.199 M ^{-20.25 %}	19.058 M ^{-75.57 %}	78.016 M
Net cash used for investing activites	-283.680 M ^{-219.35 %}	237.688 M ^{4 140.25 %}	-5.883 M ^{98.45 %}	-379.348 M
Debt repayment	10.000 M	0.000 ^{100.00 %}	-1.234 M ^{93.54 %}	-19.102 M
Common stock issued	291.057 M	0.000	0.000 ^{-100.00 %}	11.439 M
Common stock repurchased	0.000	0.000	0.000	0.000
Dividends paid	0.000	0.000	0.000	0.000
Other financing activites	-20.021 M ^{49.03 %}	-39.281 M ^{-113.70 %}	286.820 M ^{984.84 %}	-32.415 M
Net cash used provided by financing activities	281.036 M ^{815.45 %}	-39.281 M ^{-113.75 %}	285.586 M ^{812.58 %}	-40.078 M
Effect of forex changes on cash	5.632 M ^{42.98 %}	3.939 M ^{-89.34 %}	36.946 M ^{585.62 %}	-7.608 M
Net change in cash	-198.627 M ^{-33.47 %}	-148.818 M ^{-1 083.82 %}	-12.571 M ^{98.05 %}	-644.566 M
Cash at beginning of period	517.924 M ^{-22.32 %}	666.742 M ^{-1.85 %}	679.313 M ^{-48.69 %}	1.324 B
Cash at end of period	319.297 M ^{-38.35 %}	517.924 M ^{-22.32 %}	666.742 M ^{-1.85 %}	679.313 M
Operating cash flow	-201.615 M ^{42.59 %}	-351.164 M ^{-6.67 %}	-329.220 M ^{-51.34 %}	-217.532 M
Capital expenditure	-6.161 M ^{34.99 %}	-9.476 M ^{66.43 %}	-28.225 M ^{12.89 %}	-32.403 M
Free CashFlow	-207.297 M ^{42.52 %}	-360.640 M ^{-0.89 %}	-357.445 M ^{-43.02 %}	-249.935 M
	2024	2023	2022	2021

	2024-03-31	2023-12-31	2023-03-31	2022-12-31
Revenue	132.053 M ^{-25.20 %}	176.533 M ^{36.60 %}	129.232 M ^{-29.22 %}	182.575 M
Net income	-116.276 M ^{-26.15 %}	-92.172 M ^{11.41 %}	-104.044 M ^{40.60 %}	-175.161 M
Income before tax	-118.222 M ^{-24.88 %}	-94.668 M ^{11.87 %}	-107.422 M ^{41.32 %}	-183.079 M
Income before tax ratio	-0.90 ^{-66.94 %}	-0.54 ^{35.49 %}	-0.83 ^{17.11 %}	-1.00
EBITDA	-104.943 M ^{-30.59 %}	-80.359 M ^{14.19 %}	-93.648 M ^{44.52 %}	-168.786 M
Net income ratio	-0.88 ^{-68.64 %}	-0.52 ^{35.15 %}	-0.81 ^{16.08 %}	-0.96
Ratio EBITDA	-0.79 ^{-74.58 %}	-0.46 ^{37.18 %}	-0.72 ^{21.62 %}	-0.92
Gross profit ratio	0.37 ^{36.18 %}	0.28 ^{-7.55 %}	0.30 ^{6.98 %}	0.28
Weighted average shs out dil	560.417 M ^{0.00 %}	560.417 M ^{0.00 %}	560.417 M ^{0.00 %}	560.417 M
Weighted average shs out	560.417 M ^{0.00 %}	560.417 M ^{0.00 %}	560.417 M ^{0.00 %}	560.417 M
EPS diluted	-0.21 ^{-31.25 %}	-0.16 ^{15.79 %}	-0.19 ^{38.71 %}	-0.31
Earnings per share	-0.21 ^{-31.25 %}	-0.16 ^{15.79 %}	-0.19 ^{38.71 %}	-0.31
Gross profit	49.518 M ^{1.87 %}	48.610 M ^{26.29 %}	38.492 M ^{-24.28 %}	50.833 M
Income tax expense	0.000	0.000	0.000	0.000
Cost of revenue	82.535 M ^{-35.48 %}	127.923 M ^{40.98 %}	90.740 M ^{-31.12 %}	131.742 M
General and administrative expenses	4.845 M	0.000 ^{-100.00 %}	18.474 M	0.000
Selling and marketing expenses	558.000 K	0.000 ^{-100.00 %}	2.114 M	0.000
Other expenses	137.815 M ^{15 647.21 %}	-886.429 K ^{-101.22 %}	72.459 M ^{11 996.08 %}	599.029 K
Operating expenses	176.212 M ^{24.28 %}	141.789 M ^{-8.77 %}	155.428 M ^{-25.19 %}	207.767 M
Cost and expenses	258.747 M ^{195.93 %}	-269.713 M ^{-209.56 %}	246.168 M ^{172.51 %}	-339.509 M
Research and development expenses	32.994 M ^{1.21 %}	32.601 M ^{-47.74 %}	62.381 M ^{-12.15 %}	71.006 M
Selling general and administrative expenses	5.403 M ^{-95.09 %}	110.075 M ^{434.65 %}	20.588 M ^{-85.01 %}	137.360 M
Interest income	8.629 M ^{-46.98 %}	16.273 M ^{61.89 %}	10.052 M ^{145.98 %}	4.087 M
Interest expense	157.000 K ^{-38.98 %}	257.279 K ^{-52.18 %}	538.000 K ^{-14.13 %}	626.505 K
Depreciation and amortization	13.122 M ^{-6.62 %}	14.052 M ^{6.17 %}	13.236 M ^{-3.15 %}	13.667 M
Operating income	-126.694 M ^{-35.97 %}	-93.180 M ^{20.32 %}	-116.936 M ^{25.49 %}	-156.934 M
Operating income ratio	-0.96 ^{-81.77 %}	-0.53 ^{41.67 %}	-0.90 ^{-5.27 %}	-0.86
Total other income expenses net	8.472 M ^{669.15 %}	-1.489 M ^{-115.65 %}	9.514 M ^{136.39 %}	-26.145 M
	2024-03-31	2023-12-31	2023-03-31	2022-12-31

	2024-03-31	2023-12-31	2022-12-31
Net debt	-685.151 M ^{-23.39 %}	-555.288 M ^{20.53 %}	-698.762 M
Total investments	279.846 M ^{-54.21 %}	611.123 M ^{-26.14 %}	827.374 M
Total debt	13.707 M ^{-17.49 %}	16.613 M ^{-67.73 %}	51.489 M
Accumulated other comprehensive income loss	0.000 ^{-100.00 %}	879.873 M ^{252.14 %}	249.861 M
Retained earnings	-1.605 B ^{2.08 %}	-1.639 B ^{-27.85 %}	-1.282 B
Common stock	538.000 M ^{-9.17 %}	592.341 M ^{-1.94 %}	604.034 M
Total equity	1.020 B ^{-2.15 %}	1.042 B ^{-32.90 %}	1.553 B
Other non current liabilities	34.195 M ^{-7.94 %}	37.142 M ^{2.64 %}	36.188 M
Long term debt	2.086 M ^{-31.87 %}	3.062 M ^{-80.72 %}	15.882 M
Total non current liabilities	43.683 M ^{8.65 %}	40.204 M ^{-22.79 %}	52.070 M
Other current liabilities	42.595 M ^{-71.85 %}	151.340 M ^{-15.25 %}	178.566 M
Deferred revenue	124.335 M ^{-17.80 %}	151.262 M ^{-11.68 %}	171.275 M
Short term debt	24.205 M ^{78.62 %}	13.551 M ^{-61.94 %}	35.607 M
Total current liabilities	278.443 M ^{-29.33 %}	394.016 M ^{-10.34 %}	439.476 M
Total liabilities	322.126 M ^{-19.98 %}	402.559 M ^{-18.10 %}	491.547 M
Other non current assets	0.000 ^{-100.00 %}	25.467 M ^{176.49 %}	9.211 M
Long term investments	0.000 ^{-100.00 %}	5.505 M	0.000
Intangible assets	24.334 M ^{-12.94 %}	27.952 M ^{-2.48 %}	28.664 M
GoodWill	46.803 M ^{-9.17 %}	51.530 M ^{-16.81 %}	61.943 M
Goodwill and intangible assets	71.137 M ^{-10.50 %}	79.483 M ^{-12.28 %}	90.606 M
Property plant equipment net	29.649 M ^{-34.78 %}	45.459 M ^{-52.31 %}	95.314 M
Total non current assets	100.786 M ^{-35.36 %}	155.914 M ^{-20.10 %}	195.131 M
Other current assets	43.484 M ^{58.28 %}	27.473 M ^{-58.65 %}	66.441 M
Short term investments	279.846 M ^{-53.79 %}	605.618 M ^{-26.80 %}	827.374 M
cash and cash equivalents	698.858 M ^{22.20 %}	571.901 M ^{-23.77 %}	750.251 M
Cash and short term investments	978.704 M ^{-16.88 %}	1.178 B ^{-25.36 %}	1.578 B
Total current assets	1.241 B ^{-13.50 %}	1.435 B ^{-22.63 %}	1.854 B
Inventory	0.000	0.000	0.000
Net receivables	218.854 M ^{-4.72 %}	229.685 M ^{9.30 %}	210.141 M
Tax assets	0.000	0.000	0.000
Other assets	0.000	0.000	0.000
Account payables	73.220 M ^{-5.96 %}	77.863 M ^{44.11 %}	54.028 M
Tax payables	14.088 M	0.000	0.000
Deferred revenue non current	7.402 M	0.000	0.000
Minority interest	77.664 M ^{10.59 %}	70.229 M ^{-14.78 %}	82.406 M
Capital lease obligations	13.707 M ^{347.66 %}	3.062 M ^{-80.72 %}	15.882 M
Preferred stock	0.000	0.000	0.000
Other total stockholders equity	2.009 B ^{61.51 %}	1.244 B ^{-34.49 %}	1.899 B
Deferred tax liabilities non current	0.000	0.000	0.000
Other liabilities	0.000	0.000	0.000
Total assets	1.342 B ^{-15.64 %}	1.591 B ^{-22.39 %}	2.049 B
	2024-03-31	2023-12-31	2022-12-31

	2024-03-31	2023-03-31	2022-12-31
Deferred income tax	0.000	0.000	0.000
Stock based compensation	97.498 M ^{772.91 %}	-14.489 M	0.000
Change in working capital	-78.455 M ^{-53.53 %}	-51.100 M	0.000
Accounts receivables	6.765 M ^{1.45 %}	6.668 M	0.000
Inventory	0.000	0.000	0.000
Accounts payables	0.000	0.000	0.000
Other working capital	-85.220 M ^{-47.52 %}	-57.768 M	0.000
Other non cash items	-26.498 M ^{-2 062.81 %}	1.350 M ^{-99.14 %}	156.605 M
Net cash provided by operating activities	-112.555 M ^{28.95 %}	-158.425 M ^{-3 140.04 %}	-4.890 M
Investments in property plant and equipment	-512.426 K ^{63.32 %}	-1.397 M ^{66.60 %}	-4.182 M
Acquisitions net	0.000	0.000 ^{100.00 %}	-15.202 M
Purchases of investments	-108.526 M ^{72.27 %}	-391.436 M ^{51.27 %}	-803.240 M
Sales maturities of investments	378.134 M ^{-31.45 %}	551.587 M ^{-32.82 %}	821.064 M
Other investing activites	28.537 M ^{254.19 %}	8.057 M	0.000
Net cash used for investing activites	297.633 M ^{78.43 %}	166.811 M ^{10 797.09 %}	-1.559 M
Debt repayment	0.000	0.000 ^{100.00 %}	-1.356 M
Common stock issued	0.000	0.000	0.000
Common stock repurchased	0.000	0.000	0.000
Dividends paid	0.000	0.000	0.000
Other financing activites	-4.419 M ^{50.27 %}	-8.886 M ^{59.87 %}	-22.141 M
Net cash used provided by financing activities	-4.419 M ^{50.27 %}	-8.886 M ^{62.18 %}	-23.497 M
Effect of forex changes on cash	275.000 K ^{-85.37 %}	1.880 M	0.000
Net change in cash	180.934 M ^{13 011.16 %}	1.380 M	0.000
Cash at beginning of period	517.924 M ^{-22.32 %}	666.742 M	0.000
Cash at end of period	698.858 M ^{4.60 %}	668.122 M ^{-10.95 %}	750.251 M
Operating cash flow	-112.555 M ^{28.95 %}	-158.425 M ^{-3 140.04 %}	-4.890 M
Capital expenditure	-512.425 K ^{82.18 %}	-2.875 M ^{12.10 %}	-3.271 M
Free CashFlow	-113.026 M ^{29.93 %}	-161.300 M ^{-1 876.67 %}	-8.160 M
	2024	2023	2022

Date	Form 10K
2024	https://www1.hkexnews.hk/search/titlesearch.xhtml
2023	https://www1.hkexnews.hk/search/titlesearch.xhtml
2022	https://www1.hkexnews.hk/search/titlesearch.xhtml
2021	https://www1.hkexnews.hk/search/titlesearch.xhtml

Zhejiang Taimei Medical Technology Co., Ltd. 2576.HK

Finances

Zhejiang Taimei Medical Technology Co., Ltd. ^2576.HK